Urology Today.net

Site updated at Tuesday, 28 October 2014

Common Urological Problems

Diagnosis of Medical Renal Disease

  
Bookmark and Share

Medical renal diseases are those that involve principally the parenchyma of the kidneys. Hematuria, proteinuria, pyuria, oliguria, polyuria, pain, renal insufficiency with azotemia, acidosis, anemia, electrolyte abnormalities, and hypertension may occur in a wide variety of disorders affecting any portion of the parenchyma of the kidney, the blood vessels, or the excretory tract.

A complete medical history and physical examination, a thorough examination of the urine, and blood and urine chemistry examinations as indicated are essential initial steps in the workup of any patient.

History & Examination
A. FAMILY HISTORY
The family history may reveal disease of genetic origin, for example, tubular metabolic anomalies, polycystic kidneys, unusual types of nephritis, or vascular or coagulation defects that may be essential clues to the diagnosis.

Medical Renal Disease B. PAST HISTORY
The past personal history should cover infections, injuries, and exposure to toxic agents, anticoagulants, or drugs that may produce toxic or sensitivity reactions. A history of diabetes, hypertensive disease, or autoimmune disease may be obtained. The inquiry may also elicit symptoms of uremia, debilitation, and the vascular complications of chronic renal disease, but often the patient is asymptomatic and presents with abnormal laboratory findings.

Physical Examination
Pallor, edema, hypertension, retinopathy, or stigmas of congenital and hereditary disease may be detected.

Laboratory Findings
A. URINALYSIS
Examination of the urine is the essential part of the investigation.

Diagnosis of Medical Renal Disease

Medical Renal Disease

1. Proteinuria-
Proteinuria of any significant degree (2-4+) is suggestive of medical renal disease (parenchymal involvement). Formed elements present in the urine additionally establish the diagnosis. Significant proteinuria occurs in immune-mediated glomerular diseases or disorders with glomerular involvement such as diabetes mellitus, myeloma, or amyloidosis. Interstitial nephritis, polycystic kidneys, and other tubular disorders are not associated with significant proteinuria.

2. Erythrocyte casts-
Red blood cell casts point to glomerulonephritis. If red blood cell (erythrocyte) casts are not present, microscopic hematuria may or may not be of glomerular origin. Phase contrast microscope study may reveal dysmorphic changes in the erythrocytes present in the urine in patients with parenchymal renal disorders.

3. Fatty casts and oval fat bodies-
Tubular cells showing fatty changes occur in degenerative diseases of the kidney (nephrosis, glomerulonephritis, autoimmune disease, amyloidosis, and damage due to toxins such as lead or mercury).

4. Granular casts-
These types of casts result from degeneration of cellular casts. They are nondiagnostic of a specific renal disorder but do reflect an inflammatory condition in the kidneys.

B. OTHER FINDINGS
Abnormal urinary chemical constituents may be the only indication of a metabolic disorder involving the kidneys.

These disorders include diabetes mellitus, renal glycosuria, aminoacidurias (including cystinuria), oxaluria, gout, hyperparathyroidism, hemoglobinuria, and myoglobinuria.

Examination of the Kidneys & Urinary Tract
Roentgenographic, sonographic, and radioisotopic studies provide information about the size, structure, blood supply, and function of the kidneys.

Renal Biopsy
Renal biopsy is a valuable diagnostic procedure. The technique has become well established, providing sufficient tissue for light and electron microscopy and for immunofluorescence examination. Contraindications for percutaneous kidney biopsy may include the anatomic presence of only 1 kidney, severe malfunction of one kidney even though function is adequate in the other, bleeding diathesis, and an uncooperative patient.

Clinical indications for renal biopsy, in addition to the necessity for establishing a diagnosis, include the need to determine prognosis, to follow progression of a lesion and response to treatment, to confirm the presence of a generalized disease (autoimmune disorder, amyloidosis, sarcoidosis), and to diagnose renal dysfunction in a transplanted kidney. Ultrasound or computed tomography (CT) guidance provides a more effective biopsy result. More recently, laparoscopic approach has been used by some urologists.

***
Flavio G. Vincenti, MD, & William J.C. Amend, Jr., MD

***
REFERENCES

  1. Adler S: Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int 2004;66:2095.
  2. Alric L et al: Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 2004;43:617.
  3. Appel GB et al: Membranoproliferative glomerulonephritis Type II (dense deposit disease): An update. J Amer Soc Neph 2005;16: 1392.
  4. Barratt J, Feehally J: IgA nephropathy. J Amer Soc Neph 2005;16: 2088.
  5. Braden GL et al: Tubulointerstitial diseases. Am J Kidney Dis 2005; 46:560.
  6. Buhaescu I et al: Systemic vasculitis: Still a challenging disease. Am J Kidney Dis 2005;46:173.
  7. Chesney R: The changing face of childhood nephrotic syndrome. Kidney Int 2004;66:1294.
  8. Flanc RS et al: Treatment of diffuse proliferative lupus nephritis: A meta-analysis of randomized controlled trials. Am J Kidney Dis 2004;43:197.
  9. Couser WG (guest editor): Frontiers in nephrology: Membranous nephropathy. J Amer Soc Neph 2005;16:1184.
  10. Ginzler EM et al: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219.
  11. Grantham JJ: Advancement in the understanding of polycystic kidney disease: A system approach. Kidney Int 2003;64: 1154.
  12. Heering P et al: Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 2004;43:10.
  13. Hruska KA: Treatment of chronic tubulointerstitial disease: A new concept. Kidney Int 2002;61:1911.
  14. Imaging the Kidney-Radiologic Imaging 2006. (Excerpts) Nephron Clin Pract 2006;103:c19.
  15. Izzedine H et al: Oculorenal manifestations in systemic autoimmune diseases. Am J Kidney Dis 2004;43:209.
  16. Javaid B, Quigg RJ: Treatment of glomerulonephritis: Will we ever have options other than steroids and cytotoxics? Kidney Int 2005;67:1692.
  17. Nair R, Walker PD: Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 2006;69:1455.
  18. Noris M, Remuzzi G: Hemolytic uremic syndrome. J Amer Soc Neph 2005;16:1035.
  19. Perna A et al: Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review. Am J Kidney Disease 2004;44:385.
  20. Rosner MH, Bolton WK: Renal function testing. Am J Kidney Dis 2006;47:174.
  21. Rossert J: Drug-induced acute interstitial nephritis. Kidney Int 2001; 60:804.
  22. Tenenhouse HS, Murer H: Disorders of renal tubular phosphate transport. J Am Soc Neph 2003;14:240.
  23. Troyanov S et al: Renal pathology in idiopathic membranous nephropathy: A new perspective. Kidney Int 2006;69:1641.
  24. Wilmer WA et al: Management of glomerular proteinuria: A commentary. J Amer Soc Neph 2003;14:3217.



posterior urethra1 - calcifications in the blood vessels1 - microrna1 - metastatic1 - prostate tissue cells1 - nutrition1 - regional lymph nodes1 - bloodstream1 - congenital malformations1 - cardiovascular problems1 - stenosis1 - narrowing of the blood vessels1 - congenital urinary tract defects1 - premature death3 - nocturnal enuresis3 - esrd6 - urethral discharge2 - recurrent infection2 - computational biology1 - zytiga5 - congenital malformations of the kidney1 - urinary tract defects1 - urethral pain1 - dialysis30 - mood disorders1 - lupus erythematosus4 - jevtana1 - antibiotic therapy1 - external sphincter dyssynergia3 - aggressive cancers1 -